| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 08/22/2006 | US7094800 pyrrolizinones, e.g., (3S,6R,7aS)-6-amino-5-oxo-hexahydro-pyrrolizine-3-carbonitrile trifluoroacetate, used for reducing blood sugar, treating type 2 diabetes, and treating insulin resistance |
| 08/22/2006 | US7094791 Derivatives of 3-hydroxy-pyrrole-2,4-dicarboxylic acid and uses thereof |
| 08/22/2006 | US7094783 Inhibitors of serine proteases; for therapy of thromboembolic disorder |
| 08/22/2006 | US7094782 Administering pyrazolono[1,5a]-1,3,5-triazines that are alkynyl-, cyano- and 2,3-dihydrobenzofuranyl-substituted for treating supranuclear palsy |
| 08/22/2006 | US7094780 3-aminoquinazolin-2,4-dione antibacterial agents |
| 08/22/2006 | US7094778 Nervous system disorders; muscular disorders; urogenital disorders; gastrointestinal disorders; repiratory system disorders; antiallergens; side effect reduction |
| 08/22/2006 | US7094392 Heating antihistamine drug vaporize; cooling to form a condensation aerosol; kit for dispensing thin coating |
| 08/17/2006 | WO2006086484A1 Meleimide derivatives, pharmaceutical compositions and methods for treatment of cancer |
| 08/17/2006 | WO2006086464A2 Dihydroquinazolinones as 5ht modulators |
| 08/17/2006 | WO2006084835A1 N-(3-(imidazo [1,5-a]pyrimidin-4-yl)phenyl]-sulfonamides and n-[3-(imidazo[1,5-a]pyrimidin-4-yl)-phenyl]-carboxamides and their use as gabaa receptor modulators |
| 08/17/2006 | WO2006084634A1 Pyrazolo-pyrimidine derivatives as mglur2 antagonists |
| 08/17/2006 | WO2006076646A3 Heteroaryl substituted quinolin-4-ylamine analogues |
| 08/17/2006 | WO2006055734A3 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 08/17/2006 | WO2006046135A3 Pyrazolo[4,3-d] pyrimidine derivatives useful as pde-5 inhibitors |
| 08/17/2006 | WO2006028977A3 Chiral spiro compounds and their use in asymmetric catalytic reactions |
| 08/17/2006 | WO2006021213A3 Vasopressin v1a antagonists |
| 08/17/2006 | WO2005107762A3 Certain chemical entities, compositions, and methods |
| 08/17/2006 | WO2005084401A3 Aryl substituted purine analogues |
| 08/17/2006 | US20060183898 Process for preparing temozolomide |
| 08/17/2006 | US20060183896 Optically active quaternary ammonium salt, process for producing the same, and process for producing optically active alpha-amino acid derivative with the same |
| 08/17/2006 | US20060183783 2-[3-(2-cyclopentanecarbonyl-4-methyl-phenyl)-ureido]-thiazol-4-yl} acetic acid; 2-[3-(4-Methyl-2-[2-methylpropoxy] phenyl)-ureido]-thiazol-4-yl}-acetic acid; activators of glucokinase; treatment of metabolic disorders, hyperglycemic agent, syndrome x, anticholesterol, hypertension etc. |
| 08/17/2006 | US20060183762 3-aminoquinazolin-2,4-dione antibacterial agents |
| 08/17/2006 | US20060183761 Pyrrolopyrimidines useful as inhibitors of protein kinase |
| 08/17/2006 | US20060183759 Tissue transglutaminase inhibitors |
| 08/17/2006 | US20060183756 7-Difluoromethyl-5-(4-trifluoromethyl-phenyl)-pyrazolo[1,5-a]pyrimidine-3-carboxylic acid (2-chloro-5-sulfamoyl-thiophen-3-yl)-amide; metabotropic glutamate receptors antagonist; anxiolitic, analgesic, hyperglycemic agent; absorption, advantages in pharmacokinetics in distribution transport to the brain |
| 08/17/2006 | US20060183755 Tyrosine kinase inhibitors |
| 08/17/2006 | US20060183747 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 08/17/2006 | US20060183746 Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of Bruton's tyrosine kinase by such compounds |
| 08/17/2006 | US20060183738 Crystalline forms of nevirapine |
| 08/17/2006 | US20060183734 (4-cyclohexyl-phenyl)-(4H, 10H-3a,5,9-triaza-benzo[f]azulen-9-yl)-methanone; antidiuretic, anticoagulant, diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, delay of urination, or bleeding |
| 08/17/2006 | US20060183730 Novel carbapenem compounds |
| 08/17/2006 | CA2599611A1 Meleimide derivatives, pharmaceutical compositions and methods for treatment of cancer |
| 08/17/2006 | CA2597608A1 Pyrazolo-pyrimidine derivatives as mglur2 antagonists |
| 08/16/2006 | EP1690864A2 Tricyclic purine compounds and their analogs as inhibitors of cytokine signalling |
| 08/16/2006 | EP1690857A1 Modified-protein formation inhibitor |
| 08/16/2006 | EP1689752A1 Pyrazolopyrimidines |
| 08/16/2006 | EP1689751A1 5,7-diaminopyrazolo¬4,3-d|pyrimidines with pde-5 inhibiting activity |
| 08/16/2006 | EP1689750A1 6-(2,4,6-trifluorophenyl)-triazolopyrimidines, method for the production thereof, use thereof for controlling harmful fungi, and substances containing the same |
| 08/16/2006 | EP1689749A2 Process for preparing substituted 5-amino-pyrazolo- 4,3-e|-1,2,4-triazolo 1,5-c|pyrimidines |
| 08/16/2006 | EP1689736A2 Biocidal siloxane coating material containing n-halogenated amine and amide functional groups |
| 08/16/2006 | EP1689720A1 Pyrazolyl derivatives in the form of drugs for treating acute or chronic neuronal regressions |
| 08/16/2006 | EP1689704A2 Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents |
| 08/16/2006 | EP1689406A2 Heterocyclic inhibitors of mek and methods of use thereof |
| 08/16/2006 | EP1689395A2 Vinca derivatives |
| 08/16/2006 | EP1689387A2 Bicyclic inhibitors of mek and methods of use thereof |
| 08/16/2006 | EP1689233A2 Bicyclic inhibitors of mek and methods of use thereof |
| 08/16/2006 | EP1497295B1 Farnesyl transferase inhibiting tricyclic quinazoline derivatives substituted with carbon-linked imidazoles or triazoles |
| 08/16/2006 | EP1404678B1 Water-soluble porphyrin derivatives for photodynamic therapy, their use and manufacture |
| 08/16/2006 | EP1259234B1 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy |
| 08/16/2006 | EP1252160B1 Methanocarba cycloalkyl nucleoside analogues |
| 08/16/2006 | EP1028729B1 Methods of modulating serine/threonine protein kinase function with 5-azaquinoxaline-based compounds |
| 08/16/2006 | EP1019075B9 Beta 2-adrenergic receptor agonists |
| 08/16/2006 | EP0880523B1 Pyrazolopyrimidines as crf receptor antagonists |
| 08/16/2006 | CN1820010A Bridged n-arylsulfonylpiperidines as gamma-secretase inhibitors |
| 08/16/2006 | CN1820009A Pyrrolo[3,4-c]pyrazole derivatives active as kinase inhibitors |
| 08/16/2006 | CN1817884A Pyrimidinone derivatives and 3-keto ester |
| 08/16/2006 | CN1817883A New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound |
| 08/16/2006 | CN1269854C Component of polyaddition catalyst, polyaddition catalyst and process for preparing addition polymer |
| 08/16/2006 | CN1269820C Novel pyrrole derivatives as pharmaceutical agents |
| 08/16/2006 | CN1269819C Synthesis of temozolomide and analogs |
| 08/16/2006 | CN1269818C Lactam compounds and medicinal use thereof |
| 08/16/2006 | CN1269811C Piperazine derivatives having SST1 antagonistic activity |
| 08/15/2006 | US7091356 Tumor necrosis factor, to inhibit phosphodiesterase in a mammal |
| 08/15/2006 | US7091352 Antiinflammatory agents; analgesics; antiarthritic agents |
| 08/15/2006 | US7091348 Measurement of dye emission |
| 08/15/2006 | US7091347 2-substituted amino-bicyclic pyridine and pyrimidine compounds; for treatment of inflammation, inflammatory bowel disease, Alzheimer's disease, Crohn's disease, multiple sclerosis and asthma |
| 08/15/2006 | US7091345 Tyrosine kinase inhibitor; anticancer agents; antiproliferative agents; antiinflammatory agents |
| 08/15/2006 | US7091343 Compositions useful as inhibitors of protein kinases |
| 08/15/2006 | US7091338 An ion-containing compound is admixed with macromolecular crown ether or derivatives to form an extractant/ion complex, and the predetermined extractant/ion complex is separated from the diluent by using the new phase affinity |
| 08/15/2006 | US7091227 Serine/threonine and tyrosine kinases inhibitors |
| 08/15/2006 | US7091208 Janus Kinase inhibitors and optionally mixed with antiinflammatory agents, for use as immunosuppresants for prophylaxis of lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, diabetes and graft versus host diseases |
| 08/15/2006 | US7091203 Imidazo[1,3,5]triazinones and their use |
| 08/15/2006 | US7091200 adrenoceptor or G-protein coupled receptors inhibitors such as 3-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-6,7-dimethoxy-2H-benzo[1,2,4]-thiadiazine-1,1-dioxide and carriers, used for prophylaxis of urogenital disorders, or as analgesics |
| 08/15/2006 | US7090719 Compound and method for synthesizing the same, ink, ink cartridge, recording unit, ink-jet recording apparatus, recording method, liquid composition, pattern generating method, article, environmental history-detecting method |
| 08/15/2006 | CA2270558C Treatment of autoimmune diseases by photochemotherapy |
| 08/15/2006 | CA2251128C Novel process for the preparation of a protoporphyrin |
| 08/15/2006 | CA2161783C Ampa antagonists and a method of treatment therewith |
| 08/15/2006 | CA2150805C Antiallergic imidazo[1,2-a](pyrrolo, thieno or furano)[2,3-d]azepine derivatives |
| 08/10/2006 | WO2006083916A2 Novel adenosine a3 receptor modulators |
| 08/10/2006 | WO2006083687A1 Crystal salt of xanthine oxidase inhibitors |
| 08/10/2006 | WO2006083271A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 08/10/2006 | WO2006083005A1 Fused pyrimidine derivative and used thereof |
| 08/10/2006 | WO2006082145A1 Long wavelength shifted benzotriazole uv-absorbers and their use |
| 08/10/2006 | WO2006082030A1 New 4-aminoquinoline derivatives as antimalarials |
| 08/10/2006 | WO2006082001A1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1 |
| 08/10/2006 | WO2006052496A3 Compound useful for the treatment or prevention of cognitive disorders associated with diabetes and the use thereof |
| 08/10/2006 | WO2006050359A3 Pyridazine compounds and methods |
| 08/10/2006 | WO2006044415A3 Carboxylic acid peri - substituted bicyclics for occlusive artery disease |
| 08/10/2006 | WO2005079195A3 Pyrazolopyridines and analogs thereof |
| 08/10/2006 | US20060178386 For therapy of obesity, diabetes, diabetic complications, atherosclerosis, impared glucose tolerance and dyslipidemia; central nervous system diseases which includes but is not limited to, anxiety, depression, obsessive compulsive disorder, panic disorder, psychosis, schizophrenia, sleep disorder |
| 08/10/2006 | US20060178385 e.g. 1-Benzyl-7-phenyl-3-propyl-1H-pyrrolo[1,2-f]purine-2,4(3H,6H)-dione; antiinflammatory, anticarcinogenic agent; cerebral ischemia, asthma, neurodegeneration, glaucoma, ischemic heart pre-conditioning; diagnostic agents |
| 08/10/2006 | US20060178384 2-(2,6-dimethoxy-phenylamino)-9-methoxy-6,7-dihydro-pyrimido[6,1-a]isoquinolin-4-one; 3-bromo-N-[3-(9-methoxy-4-oxo-6,7-dihydro-4H-pyrimido[6,1-a]isoquinolin-2-ylamino)-phenyl]-benzamide; kinase inhibitor; neutropenia; cytopenia; anemias |
| 08/10/2006 | US20060178381 GlyT-1 inhibitors; CNS disorders such as psychoses, dysfunction in memory and learning, schizophrenia, dementia, attention deficit disorders, or Alzheimer's disease; (2-isobutoxy-5-methanesulfonyl-phenyl)-(3-trifluoromethyl-5,7-dihydro-pyrrolo[3,4-b]pyridin-6-yl)-methanone and pyrrolo[3,4-c]pyridines |
| 08/10/2006 | US20060178378 Novel kinase inhibitors |
| 08/10/2006 | US20060178377 e.g. Ethyl 6-(azidomethyl)-5-(2,4-dichlorophenyl)-7-methylimidazo[1,2-a]pyrimidine-2-carboxylate; treating diabetes and micro- and macrovascular complications of diabetes, such as retinopathy, neuropathy, and nephropathy |
| 08/10/2006 | US20060178371 7-amino-pyrrazolo[1,5-a]pyrimidine derivatives, useful in the treatment and prevention of proliferative diseases, for example, cancer, inflammation and arthritis |
| 08/10/2006 | US20060178367 Certain imidazo[1,2-a]pyrazin-8-ylamines, method of making, and method of use thereof |
| 08/10/2006 | US20060178366 Compounds for the treatment of inflammatory disorders |
| 08/10/2006 | US20060178362 Substituted heterocyle fused gamma-carbolines |
| 08/10/2006 | US20060178359 Tricyclic compound, process for producing the same, and use |